share_log

Ladenburg Thalmann Downgrades Ayala Pharmaceuticals to Neutral

Benzinga ·  Nov 16, 2023 14:12

Ladenburg Thalmann analyst Ahu Demir downgrades Ayala Pharmaceuticals (OTC:ADXS) from Buy to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment